Terumo Partners with Hemex to Enhance Sickle Cell Care
Terumo Blood and Cell Technologies (Terumo BCT) is collaborating with Hemex Health to improve diagnosis and treatment for millions affected by sickle cell disease and other hemoglobin disorders. This partnership follows Terumo’s minority investment in Hemex Health and the appointment of Chetan Makam to Hemex’s Board of Directors. The collaboration aims to enhance access to…more










